Karriereverlauf von Nicholas Vlahakis
Ehemalige bekannte Positionen von Nicholas Vlahakis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| COHBAR, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | 01.05.2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Nicholas Vlahakis
| University of Adelaide | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Australien | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Nicholas Vlahakis
- Erfahrung
